Major molecular response achievement in CML Patients can be predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS ratio at an earlier time point of follow-up than currently recommended.

Huet, Sarah

Major molecular response achievement in CML Patients can be predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS ratio at an earlier time point of follow-up than currently recommended. [electronic resource] - PloS one 2014 - e106250 p. digital

Publication Type: Journal Article

1932-6203

10.1371/journal.pone.0106250 doi


Adult
Aged
Aged, 80 and over
Female
Follow-Up Studies
Fusion Proteins, bcr-abl--genetics
Gene Expression Regulation, Neoplastic--drug effects
Glucuronidase--genetics
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--diagnosis
Male
Middle Aged
Protein Kinase Inhibitors--pharmacology
RNA, Messenger--genetics
Treatment Outcome